Niamh Lennon-Lynam
Maynooth, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
The insider's perspective: The intracellular complosome and immune cell dynamics in cancer.
Journal: Clinical and translational medicine
Published: November 13, 2025
A multi-omic biomarker signature in pre-treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment.
Journal: Clinical and translational medicine
Published: October 23, 2025
Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia.
Journal: Cancer letters
Published: October 01, 2024
Complement is increased in treatment resistant rectal cancer and modulates radioresistance.
Journal: Cancer letters
Published: April 10, 2024
Generation and Characterization of an Isogenic Cell Line Model of Radioresistant Esophageal Adenocarcinoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 18, 2023
Metformin is a metabolic modulator and radiosensitiser in rectal cancer.
Journal: Frontiers in oncology
Published: May 04, 2023
PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma.
Journal: Frontiers in immunology
Published: January 25, 2023
Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer.
Journal: World journal of gastrointestinal oncology
Published: January 14, 2023
Energy Metabolism Is Altered in Radioresistant Rectal Cancer.
Journal: International journal of molecular sciences
Published: January 10, 2023
Last Updated: 09/26/2026